Magnetar Financial LLC Makes New $1.43 Million Investment in Prestige Consumer Healthcare Inc. $PBH

Key Points

• Magnetar Financial LLC has invested approximately $1.43 million in Prestige Consumer Healthcare Inc., acquiring 16,668 shares in the first quarter.
• Prestige Consumer Healthcare reported earnings of $0.95 per share for the last quarter, falling short of analyst estimates of $1.01, and experienced a 6.6% decline in revenue year-over-year.
• The stock has received mixed ratings from analysts, with a consensus rating of "Moderate Buy" and a target price of $93.33.

Magnetar Financial LLC acquired a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 16,668 shares of the company's stock, valued at approximately $1,433,000.

A number of other large investors also recently made changes to their positions in the company. Cerity Partners LLC increased its stake in shares of Prestige Consumer Healthcare by 3.7% during the first quarter. Cerity Partners LLC now owns 3,666 shares of the company's stock worth $315,000 after purchasing an additional 132 shares during the period. KBC Group NV increased its stake in shares of Prestige Consumer Healthcare by 7.4% during the first quarter. KBC Group NV now owns 2,199 shares of the company's stock worth $189,000 after purchasing an additional 151 shares during the period. McIlrath & Eck LLC increased its stake in shares of Prestige Consumer Healthcare by 19.1% during the fourth quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock worth $75,000 after purchasing an additional 154 shares during the period. Xponance Inc. increased its stake in shares of Prestige Consumer Healthcare by 5.5% during the first quarter. Xponance Inc. now owns 3,766 shares of the company's stock worth $324,000 after purchasing an additional 196 shares during the period. Finally, Resona Asset Management Co. Ltd. increased its stake in shares of Prestige Consumer Healthcare by 2.3% during the first quarter. Resona Asset Management Co. Ltd. now owns 9,105 shares of the company's stock worth $783,000 after purchasing an additional 203 shares during the period. Institutional investors own 99.95% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on PBH shares. Canaccord Genuity Group lowered their target price on Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Wall Street Zen lowered Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Finally, Royal Bank Of Canada upgraded Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Three analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $93.33.

Prestige Consumer Healthcare Price Performance

Shares of PBH traded up $0.46 during midday trading on Wednesday, hitting $66.96. The company's stock had a trading volume of 630,789 shares, compared to its average volume of 402,712. Prestige Consumer Healthcare Inc. has a one year low of $62.95 and a one year high of $90.04. The company's fifty day simple moving average is $72.64 and its two-hundred day simple moving average is $80.20. The company has a quick ratio of 2.99, a current ratio of 4.38 and a debt-to-equity ratio of 0.55. The stock has a market capitalization of $3.30 billion, a price-to-earnings ratio of 15.72, a price-to-earnings-growth ratio of 2.15 and a beta of 0.46.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.95 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.01 by ($0.06). Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The business had revenue of $249.53 million during the quarter, compared to the consensus estimate of $260.71 million. During the same quarter in the previous year, the business posted $0.90 EPS. The company's revenue for the quarter was down 6.6% on a year-over-year basis. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. As a group, equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.